Reaction Details Report a problem with these data
Target
Bromodomain-containing protein 4 [42-168]
Ligand
BDBM318511
Substrate
n/a
Meas. Tech.
AlphaScreen Assay A2
IC50
<100±n/a nM
Citation
 Combs, AP; Sparks, RB; Maduskuie, Jr., TP; Rodgers, JD Tricyclic heterocycles as BET protein inhibitors US Patent  US10464947 Publication Date 11/5/2019 
Target
Name:
Bromodomain-containing protein 4 [42-168]
Synonyms:
BRD4 | BRD4 BD1 (aa 42-168) | BRD4_HUMAN | Bromodomain-containing protein 4 Bromo Domain 1 | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
15054.68
Organism:
Homo sapiens (Human)
Description:
O60885[42-168]
Residue:
127
Sequence:
STNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE
  
Inhibitor
Name:
BDBM318511
Synonyms:
7-(3,5-Dimethylisoxazol-4-yl)-4,9-diphenyl-4,5-dihydroimidazo[1,5,4-de][1,4]benzoxazin-2(1H)-one | US10464947, Example 43 | US11498926, Example 43 | US9624241, Example 43
Type:
Small organic molecule
Emp. Form.:
C26H21N3O3
Mol. Mass.:
423.4632
SMILES:
Cc1noc(C)c1-c1cc(-c2ccccc2)c2[nH]c(=O)n3C(COc1c23)c1ccccc1 |(-1.48,-6.16,;-2.82,-5.39,;-4.28,-5.87,;-5.19,-4.62,;-4.28,-3.37,;-5.05,-2.04,;-2.82,-3.85,;-1.48,-3.08,;-.15,-3.85,;1.18,-3.08,;2.52,-3.85,;2.52,-5.39,;3.85,-6.16,;5.19,-5.39,;5.19,-3.85,;3.85,-3.08,;1.18,-1.54,;2.52,-.77,;1.39,.77,;2.16,2.1,;-.15,.77,;-1.48,1.54,;-2.82,.77,;-2.82,-.77,;-1.48,-1.54,;-.15,-.77,;-1.48,3.08,;-.15,3.85,;-.15,5.39,;-1.48,6.16,;-2.82,5.39,;-2.82,3.85,)|
Structure:
Search PDB for entries with ligand similarity: